Recent Press Releases

Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting

Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab

European Commission grants Lilly and Boehringer Ingelheim's insulin glargine product marketing authorisation in Europe

First biosimilar insulin to receive regulatory approval in the EU

INDIANAPOLIS and RIDGEFIELD, Conn.,

Generic Pharmaceutical Savings Reach Highest-Ever Watermark of $239 Billion in 2013

Ten-year savings hits record at nearly $1.5 trillion according to annual Generic Drug Savings in the U.S. report WASHINGTON, DC (Sept. 10, 2014) — The Generic Pharmaceutical Association (GPhA)...

SPECIAL DRUG SAFETY REPORT DETAILS 49,000 PREVIOUSLY UNDISCLOSED SIDE EFFECT REPORTS

SPECIAL DRUG SAFETY REPORT DETAILS 49,000 PREVIOUSLY UNDISCLOSED SIDE EFFECT REPORTS REPORT AT TEDMED 2014 HIGHLIGHTS DATA MINING'S ROLE IN IMPROVING PUBLIC SAFETY SANTA ROSA, Calif., September 10,...

Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression

Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression New data showed patients who had the highest rates of brain...

FDA Advisory Committee Recommends Against Approval of Actavis' Nebivolol/Valsartan Fixed-Dose Combination NDA for Treatment of Hypertension

FDA Advisory Committee Recommends Against Approval of Actavis' Nebivolol/Valsartan Fixed-Dose Combination NDA for Treatment of Hypertension DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Actavis plc...

Drug Launch, Market Activity, Appointments, and Special Meeting of Shareholders - Research Reports on Teva, Universal Health, Tenet, Allergan and Valeant

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, September 9, 2014<

The cost of nab-paclitaxel is not justified by its limited benefit, says NICE in draft guidance

The cost of nab-paclitaxel is not justified by its limited benefit, says NICE in draft guidance NICE has published new draft guidance which recommends that nab-paclitaxel taken with gemcitabine...

Pfizer Canada contributes EpiPen® (epinephrine) Auto-Injectors to Hamilton pilot project

Pfizer Canada contributes EpiPen® (epinephrine) Auto-Injectors to Hamilton pilot project City's pilot project to improve public health safety is first of its kind in Canada TORONTO, Sept. 8,...

Par Pharmaceutical Resumes Shipment of Generic Precedex® Injection

Par Pharmaceutical Resumes Shipment of Generic Precedex® Injection WOODCLIFF LAKE, N.J., Sept. 8, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has resumed...

FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease Approval aligns with Centers for Disease Control and Prevention's recommendations for...

Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibody Program from AnaptysBio

SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease

SAN DIEGO, Sept.

New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs

-Innovative Abbott testing technology may help to identify severe infections sooner

WASHINGTON, Sept.

Safety and Sustained Benefits of Adempas® From Bayer Confirmed by Results of Long-Term Studies

Analysis of long-term extension studies CHEST-2 and PATENT-2 confirms long-term safety profile of riociguat over two years in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and...

Endo announces launch of Authorized Generic of FORTESTA® Gel

Endo announces launch of Authorized Generic of FORTESTA® Gel First and only generic 2% topical testosterone gel Product launched by Qualitest is now available DUBLIN, Sept. 8, 2014 /PRNewswire/...

Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at ECTRIMS

Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at ECTRIMS

Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex(TM)

Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex(TM) Mylan Free to Immediately Resume Distribution of Its Generic Precedex Product PITTSBURGH, Sept. 8, 2014...

Amgen To Present At The Morgan Stanley Global Healthcare Conference

THOUSAND OAKS, Calif., Sept.

Roche announces change in Board of Directors

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Arthur D. Levinson has resigned from the Board of Directors, effective immediately. Arthur D. Levinson made this decision so as to avoid any...